Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,505 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[A case with chronic hepatitis C who developed liver cirrhosis due to liver dysfunction caused by pegylated interferon plus ribavirin treatment despite negativity of serum HCV RNA, during therapy].
Ohkoshi S, Morita S, Tanaka Y, Yano M, Takeuchi M, Takahashi H, Ikeda H, Yamagiwa S, Matsuda Y, Nomoto M, Aoyagi Y. Ohkoshi S, et al. Among authors: takahashi h. Nihon Shokakibyo Gakkai Zasshi. 2011 Feb;108(2):267-74. Nihon Shokakibyo Gakkai Zasshi. 2011. PMID: 21307632 Japanese.
Characterization of elevated alanine aminotransferase levels during pegylated-interferon α-2b plus ribavirin treatment for chronic hepatitis C.
Aoki YH, Ohkoshi S, Yamagiwa S, Yano M, Takahashi H, Waguri N, Igarashi K, Sugitani S, Takahashi T, Ishikawa T, Kamimura T, Wakabayashi H, Watanabe T, Matsuda Y, Nomoto M, Aoyagi Y. Aoki YH, et al. Among authors: takahashi h, takahashi t. Hepatol Res. 2011 Feb;41(2):118-25. doi: 10.1111/j.1872-034X.2010.00749.x. Hepatol Res. 2011. PMID: 21269381
Failure to achieve 2-log10 viral decrease in first four weeks of peg-IFNalpha-2b plus ribavirin therapy for chronic hepatitis C with genotype 1b and high viral titer is useful in predicting non-response: evaluation of response-guided therapy.
Ohkoshi S, Yamagiwa S, Yano M, Takahashi H, Aoki YH, Waguri N, Igarashi K, Sugitani S, Takahashi T, Ishikawa T, Kamimura T, Wakabayashi H, Watanabe T, Matsuda Y, Aoyagi Y. Ohkoshi S, et al. Among authors: takahashi h, takahashi t. Hepatogastroenterology. 2011 May-Jun;58(107-108):965-70. Hepatogastroenterology. 2011. PMID: 21830425
Efficacy of Combined Encorafenib and Binimetinib Treatment for Erdheim-Chester Disease Harboring Concurrent BRAFV600E and KRASG12R Mutations: A Case Report.
Hibino Y, Sakai R, Takahashi H, Takeda T, Hirose N, Tokunaga M, Washimi K, Yokose T, Kasajima R, Hiroshima Y, Miyagi Y, Nakajima H. Hibino Y, et al. Among authors: takahashi h. Cancer Rep (Hoboken). 2024 Dec;7(12):e70093. doi: 10.1002/cnr2.70093. Cancer Rep (Hoboken). 2024. PMID: 39724464 Free PMC article.
14,505 results
You have reached the last available page of results. Please see the User Guide for more information.